Epigenomics AG (FRA:ECX)

Epigenomics AG Revenue

Epigenomics AG had revenue of 4.00K EUR in the half year ending June 30, 2025, a decrease of -98.03%. This brings the company's revenue in the last twelve months to 4.00K, down -97.06% year-over-year.

• Revenue (ttm): 4.00K
• Revenue Growth: -97.06%
• P/S Ratio: 219.24
• Revenue / Employee: 1.33K
• Employees: 2
• Market Cap: 876.95K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	339.00K	-560.00K	-62.29%
Dec 31, 2022	899.00K	-5.30M	-85.51%
Dec 31, 2021	6.20M	5.36M	636.70%
Dec 31, 2020	842.00K	-283.00K	-25.16%